Bridging Nations to Accelerate Global Health Innovation
A pilot program helping clinical-stage life science companies expand into new markets through the Access Consortium—five trusted regulatory authorities, one structured pathway.
Bridging Nations to Accelerate Global Health Innovation
A pilot program helping clinical-stage life science companies expand into new markets through the Access Consortium—five trusted regulatory authorities, one structured pathway.
What is Access BioBridge?
BioBridge is a 6–10 month pilot program that helps clinical-stage life science companies expand into new markets through the Access Consortium, a coalition of five trusted regulatory authorities.
The program connects companies with regulatory guidance, validation infrastructure, strategic partners, and investors in their target market. The pilot phase opens a Canada-to-UK corridor, with additional corridors to follow.
Connect
Link innovators with regulators, investors & service providers across borders
Accelerate
Fast-track regulatory pathways and approvals across five nations
Commercialize
Scale solutions to global markets through trusted partnerships
Five Nations, One Mission
A coalition of trusted regulatory authorities working together to accelerate access to innovative health technologies for their combined populations.
United Kingdom
Australia
Canada
Switzerland
Singapore
Breaking Down Barriers to Global Growth
Cross-border expansion is slow, expensive, and full of blind spots. Clinical-stage companies struggle to navigate new regulatory systems, build local networks, and secure the infrastructure they need to validate and commercialize in unfamiliar markets.
Common challenges companies face:
The Solution
BioBridge provides a landing pad for international companies to navigate and establish themselves in the Canadian market—while opening global pathways for Canadian innovators.
One program. Two-way global access.
Why Join BioBridge?
BioBridge delivers strategic value for Canadian stakeholders across government, industry, and healthcare systems.
Expands Global Market Access
Opens international pathways for Canadian health and life sciences companies.
Attracts Foreign Investment
Draws global capital and strategic partnerships into Canada's ecosystem.
Builds Regional Capacity
Generates service revenue and high-value jobs across Canadian innovation hubs.
Solves Provincial Healthcare Gaps
Fills technology gaps present in our healthcare systems.
Strengthens Canada's Global Positioning
Establishes Canada as a trusted leader in health innovation and regulatory collaboration.
How to Get Involved
Join the effort to position Canada at the forefront of global life sciences innovation.
Provide Funding Support
Contribute to Canada's share of the pilot program and help accelerate health innovation across the nation.
Become a FunderEnable Regional Participation
Help host incoming international firms and deliver R&D services through Canadian innovation hubs.
Partner With UsNominate Companies
Encourage high-potential Canadian firms to apply. Applications open late 2025.
Submit NominationPriority Focus Areas for UK/Canada Program Nominations
The Pilot Program is currently centered on Canadian companies aiming to enter the UK market. Each pilot phase accepts 2–3 companies from the originating nation. The program specifically seeks Medical Devices, Software as a Medical Device (SaMD), and novel treatments that align with unmet needs in the target market.
Radiopharmaceuticals
Stage Criteria
- Targeted radiopharmaceutical with preclinical proof-of-concept complete, ready for first-in-human studies
- Theranostic pair validated in preclinical models with dosimetry data available
- Manufacturing process established with GMP-compatible radiolabeling demonstrated
Regulatory Criteria
- Home market regulatory pathway initiated or pre-submission meeting completed
- Radioisotope supply chain and transportation logistics documented for target market
Ready to Shape the Future of Health Innovation?
Join Canada's participation in the Access Consortium pilot program. Connect with us to explore funding, partnership, and participation opportunities.